4-Methylaminorex

4-Methylaminorex (4-MAR) is a psychoactive drug and stimulant that was first synthesized in the mid-20th century. It is structurally related to both amphetamine and methamphetamine, but its pharmacological profile is somewhat distinct. 4-Methylaminorex has been found to produce euphoria, increased energy, and heightened alertness. Due to its potent stimulant effects, it has been subject to abuse, leading to its classification as a controlled substance in many countries.
Chemistry[edit]
4-Methylaminorex exists in two enantiomeric forms, with the (+)-enantiomer being the more active form in terms of its stimulant properties. It is a cyclic derivative of phenethylamine, featuring a 2-amino-4-methyl-5-phenyl oxazoline core. Its synthesis can be achieved through various chemical pathways, often involving the cyclization of precursor molecules under specific conditions.
Pharmacology[edit]
The mechanism of action of 4-Methylaminorex primarily involves the release of dopamine and norepinephrine, two key neurotransmitters in the brain's reward and alertness pathways. This action is similar to that of other stimulants, which accounts for its effects on mood, energy levels, and cognitive functions. However, 4-Methylaminorex also exhibits a higher selectivity for certain neurotransmitter systems, which may contribute to its unique pharmacological profile.
Effects[edit]
Users of 4-Methylaminorex report a range of effects, including intense euphoria, increased alertness, and enhanced cognitive function. However, these desirable effects are accompanied by a risk of adverse reactions, such as hypertension, tachycardia, and in severe cases, neurotoxicity. The drug's potent stimulant properties also raise the potential for abuse and addiction.
Legal Status[edit]
Due to concerns over its potential for abuse and harm to public health, 4-Methylaminorex has been classified as a controlled substance in many countries around the world. This classification restricts its manufacture, distribution, and possession, except under specific, regulated circumstances.
See Also[edit]
|
This article is a stub You can help WikiMD by registering and expanding it with useful details, internal links, formatting, and categories. Editing is available only to registered and verified users. WikiMD is a comprehensive, free health and wellness encyclopedia. |
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian